Contract 75H71224P00137
Four Points Technology, L.L.C. · Department Of Health And Human Services · September 26, 2024
Four Points Technology, L.L.C. was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on September 26, 2024 for $247,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Phoenix, AZ. It was awarded under a Veteran-Owned Small Business set-aside. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 31, 2026. If all options are exercised, the contract could reach $292,000.
Contract details
- PIID
- 75H71224P00137
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Service Disabled Veteran Owned Small Business Set-Aside
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Phoenix, AZ
- First action
- September 26, 2024
- Latest action
- March 31, 2026
Description
PYXIS ADD-ON EQUIPMENT - PIMC
Modification timeline
-
March 31, 2026Mod P00005 · Supplemental Agreement For Work Within Scope$246.6K
-
November 6, 2025Mod P00004 · Supplemental Agreement For Work Within Scope$246.6K
-
September 26, 2024Mod P00001 · Other Administrative Action$246.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 27, 2026 | $176.14M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71224P00137?
Contract 75H71224P00137 is a federal contract awarded to Four Points Technology, L.L.C. by Department Of Health And Human Services on September 26, 2024 for $247,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75H71224P00137?
Four Points Technology, L.L.C. won contract 75H71224P00137 from Department Of Health And Human Services.
How much is contract 75H71224P00137 worth?
Contract 75H71224P00137 has obligated $0 to date but carries a potential ceiling of $292,000 if fully funded and all options are exercised.